Evaluating the Value of a Payer Contract

Published in Government Relations on June 24, 2025

By Melanie Ewald, VP of Payer Relations and Reimbursement, VGM  

In our last article, Key Payers Denied Your Application Citing Their Network Is Closed – Now What?, we discussed strategies for addressing payer contracting denials due to a closed network. As indicated, this process can be an extremely time-consuming exercise with no guarantees and mixed results. Below are a few things to consider as you evaluate whether a contract is worth the extra effort. 

DMEPOS providers continue to navigate a minefield of challenges such as shrinking margins, regulatory complexities, and challenges with payer reimbursement and contracting. Deciding whether to enter or remain in-network with a given payer is one of the most critical decisions DME providers will make. Getting in-network under the right contract can expand access to more patients and thus increase revenue.  

Entering or remaining in the wrong contract can chip away at your profitability. You are not required to accept every contract offered to you. Consider the following as you evaluate new and existing contract opportunities. 

Does the contract bring in new patients? Does it increase your ability to say “Yes” more often to referral sources? Are you getting paid more than what you paid to acquire the product? Do you require profit on every transaction? Each of these points is important on their own; however, even when combined, they do not necessarily make a contract worth having or viable.  

Viable long-term contracts provide for at least the following: 

  • Reimbursement covers ALL costs, not just product acquisition. 
  • Policies are actually followed as prescribed in the contract and provider manuals. 
  • Transparent notice process for contract amendments and policy updates. 
  • Clearly defined resolution process for when issues arise. 

Pay close attention to arrangements that may have hidden profit diminishers such as: 

  • Administratively burdensome requirements that increase your costs. i.e., employee time required to handle frequent prior authorizations and denial management due to unclear documentation requirements and unclear appeals processes. 
  • High volume low-reimbursement arrangements may provide access to more patients, but will not fix profit margins and may drain critical resources. 

Today’s payer environment is such that not every contract is worth having and some could ultimately be detrimental to your business. Each contract, particularly those requiring extensive effort and resources to execute, should be evaluated closely with profitability, operational efficiency, and strategic fit in mind. 

From Our Experts

The Big Sky Association of Medical Equipment Suppliers Welcomes UTAH! thumbnail The Big Sky Association of Medical Equipment Suppliers Welcomes UTAH! The Big Sky Association of Medical Equipment Suppliers is pleased to announce that Utah has officially been accepted into the association as our newest participating state. Big Sky now proudly welcomes all Utah DME/HME, Respiratory, CRT, and Medical Supply companies into our regional association. Utah will have a designated state representative/director—appointed in the same manner as Montana, Idaho, and Wyoming—to ensure strong representation and a clear voice within the Association. Beyond the Shutdown and The Proposed Rule: Key Legislative Updates for the HME Industry thumbnail Beyond the Shutdown and The Proposed Rule: Key Legislative Updates for the HME Industry While the government shutdown and uncertainty surrounding CMS's Proposed Rule have dominated headlines, several important bills impacting HME providers continue to advance. Here's a quick look at three focused legislative priorities: Advocacy in Action: Texas DME Providers Stand Up For Patient Care thumbnail Advocacy in Action: Texas DME Providers Stand Up For Patient Care Texas DME providers are speaking out against proposed Medicaid reimbursement rate cuts that threaten access to essential medical equipment for vulnerable patients. At a recent public hearing, voices from across the state shared powerful stories about the real-world impact of these cuts—some as high as 85%. The Shutdown Has Ended—Now It's Time To Take Action thumbnail The Shutdown Has Ended—Now It's Time To Take Action The recent government shutdown created uncertainty across the healthcare landscape, and the DMEPOS community was no exception. In the weeks ahead, critical decisions will shape the future of our industry. By getting involved early—through advocacy, education, and collaboration—you can help ensure these policies support patients and providers rather than hinder them. Notably, the Continuing Resolution (CR) includes an extension of Medicare telehealth flexibilities through January 2026... New Issue Brief: Why Medicare's Competitive Bidding Program Needs Urgent Reform thumbnail New Issue Brief: Why Medicare's Competitive Bidding Program Needs Urgent Reform The Medicare competitive bidding program for durable medical equipment (DME) was designed to reduce costs—but it's failing patients and providers. A new issue brief from Pacific Research Institute and economist Wayne Winegarden highlights what changes are urgently needed. Champions of Change: DME Advocates Driving Real Change thumbnail Champions of Change: DME Advocates Driving Real Change Real change starts with real people. In this edition of Champions of Change, we're spotlighting two DME advocates who aren't just talking about problems—they're taking action. David Griffin and Gary Rench are showing us what it means to stand up for patients, providers, and the future of our industry. Join HME Industry Letter on CB Program to CMS Administrator Oz thumbnail Join HME Industry Letter on CB Program to CMS Administrator Oz HME suppliers, manufacturers, and distributors are invited to add their company's name to a letter to CMS Administrator Dr. Mehmet Oz regarding the Administration's DMEPOS/Home Health Proposed Rule that includes provisions for a new competitive bidding round. The letter specifically asks CMS to withdraw or delay the DMEPOS provisions in the Proposed Rule and re-engage with industry, patient, and clinical stakeholders to design an evidence-based, fraud-resistant, America-First framework. Take Action Today: Urge CMS to Pause and Re-Evaluate the Competitive Bidding Program thumbnail Take Action Today: Urge CMS to Pause and Re-Evaluate the Competitive Bidding Program Now is the time to raise our voices. With the formal announcement of the Competitive Bidding (CB) Program expected as early as the end of this month, we must act swiftly and decisively. Below are two key opportunities to engage with your U.S. Representative and encourage their support for a Congressional letter urging Centers for Medicare & Medicaid Services (CMS) to pause and reassess the CB Program.